Position in GILD
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$767,768
+$696,996 QoQ
Shares Held
6,077
+442.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
#1,192
of 2,266 holders
Holding Since
Mar 2020
4 quarters on record
Voting authority
Sole 12%
Shared 0%
None 88%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Weaver Consulting Group holds $4,407,808 across 7 Drug Manufacturers - General names. GILD ranks #2 (17.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
5,013 | $1,273,151 | |
| 2 | GILD |
Gilead Sciences, Inc.
This page
|
6,077 | $767,768 | |
| 3 | LLY |
ELI LILLY & Co
|
551 | $660,885 | |
| 4 | AMGN |
Amgen Inc
|
1,633 | $591,341 | |
| 5 | MRK |
Merck & Co., Inc.
|
4,026 | $517,341 | |
| 6 | ABBV |
AbbVie Inc.
|
1,228 | $309,013 | |
| 7 | PFE |
Pfizer Inc
|
11,973 | $288,309 |
All Filings in GILD
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $767,768 | 6,077 | Shares | Sole | 2026-07-29 | |
| 2020-09-30 | $70,772 | 1,120 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $98,483 | 1,280 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $91,581 | 1,225 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||